Advanced regulatory framework supports timely access for innovative therapies.
Life Science
Japan Entry Acceleration Program
A 16-week accelerator connecting regenerative medicine
companies with Japan’s leading life science ecosystem.
Your Gateway to Japan and Beyond
JEAP helps regenerative medicine companies navigate Japan, identify the right partners, and turn market interest into real collaboration.
-
Applications in 2025
70
-
Countries
25
-
Selected companies
10
-
Demo Day participants
100
Why Global Companies Choose Japan
-
Advanced regulatory
-
World-Leading Research
Cutting-edge science fuel the next generation of regenerative medicine.
-
Advanced Manufacturing
Precision, quality, and scalability supported by world-class manufacturing capabilities.
-
Gateway to Asia
Strategically located to expand your impact and grow across Asia and beyond.
How JEAP Works
JEAP turns Japan's ecosystem and regulatory advantages into a company-specific market-entry plan.
-
01
Assess Japan fitClarify clinical, regulatory, manufacturing and partnership priorities.
-
02
Navigate with expertsBuild a tailored strategy through one-to-one mentoring.
-
03
Meet the right partnersJoin curated meetings with researchers, pharma, CDMOs, CROs and investors.
-
04
Activate in JapanMove discussions forward through site visits and Demo Day.
Ready to Build in Japan?
For overseas companies with an identified regenerative medicine,
cell therapy, gene therapy or tissue-engineered development candidate.
Contact Us
Investing in and collaborating with Japan
We will do our very best to support your business expansion into and within Japan as well as business collaboration with Japanese companies. Please feel free to contact us via the form below for any inquiries.
Inquiry Form
JETRO Worldwide
Our network covers over 50 countries worldwide. You can contact us at one of our local offices near you for consultation.
